Intellectual property: Patents in France

Armengaud Guerlain

Armengaud Guerlain, a boutique fully dedicated to IP law, excels in prosecution and litigation matters across patents, trademarks, designs and copyright. Co-head Stéphane Guerlain, with over 35 years’ experience, leads contentious matters blending strategic advice and procedural expertise, while co-head Catherine Mateu covers international desks, focusing on cross-border enforcement and UPC representation. Betty Dachary supports SEP negotiations, Flora Erbibou is a key contact for evidence-driven disputes, and Pierre Camadini aids with UPC pleadings. The firm’s multilingual, collaborative approach and innovative remote capabilities ensure cost-effective, high-quality service for global clients.

Responsables de la pratique:

Stéphane Guerlain; Catherine Mateu


Autres avocats clés:

Betty Dachary; Flora Erbibou; Pierre Camadini


Principaux clients

NJ DIFFUSION


ECAREYOU


MERCK MILLIPORE


ESTAR – MEDICAL LEADING PHARMACEUTICAL COMPANY (CELL REGENERATION)


IMV TECHNOLOGIES


WIKO


NOVAPET


TTK


TELECOM DESIGN


LINXENS


LA BOULANGÈRE


PERREIN


Principaux dossiers


  • Acting for the defendant in a patent infringement action. Obtained twice a stay on the patent infringement proceedings on bioreactors that were initiated more than 5 years ago by our opponent, who has also been condemned twice to pay legal fees.
  • Defending a client against patent infringement claims before the Paris Court of First Instance regarding a pharmaceutical process used for an anti-ageing product.
  • Defending patent holder ECAREYOU in a patent validity dispute before the Paris Central Division of the UPC, launched by FRIDABABY

August Debouzy

August Debouzy boasts a leading patents practice distinguished by its balanced integration of lawyers and patent attorneys, many dual-qualified as European patent attorneys and equipped to handle Unified Patent Court representations. The team excels in comprehensive patent services, from high-stakes litigation and EPO oppositions to strategic prosecution, freedom-to-operate analyses, and licensing. The practice is jointly steered by François Pochart and Grégoire Desrousseaux, both engineers-turned-lawyers with deep expertise in life sciences, telecoms, and mechanics, and Lionel Martin, who specialises in litigation across the telecoms, energy, medical devices and automotive sectors. Julia Cohen-Solal advises French and foreign clients on their industrial property strategy, in particular for patent matters.

Responsables de la pratique:

François Pochart; Grégoire Desrousseaux; Lionel Martin


Autres avocats clés:

Océane Millon de La Verteville;  Anaïs Pallut


Les références

‘The team was highly recommended by a well-known IP firm in Germany. The patent team is well-organised and efficient, led by well-experienced counsels and supported by hard-working younger counsels. ’

‘François Pochart showed great experience in the EPO practice and a deep understanding of technology and European case law, and led the case successfully. I worked with Lionel Martin in a patent infringement case before the French court. The case sometimes required quick action in relation to the seizure and unexpected submissions by the other party, but he and his team were always flexible and led the case in our favour. ’

‘Effective collaboration among the team members at the firm.’

‘Anaïs Pallut stands out for her skills, responsiveness and communication throughout the process.’

‘Strong reputation in the patents space.’

‘Extremely competent in legal matters and very responsive. Inspires a great deal of confidence.’

 

Principaux dossiers


  • Representing Raccords et Plastiques Nicoll as claimant in an infringement action against First, brought before the LD Paris.
  • Assisting Unilever with an infringement action before the French local division launched by IGB S.r.l.
  • Represented Teva in defending two PI requests launched by Biogen regarding Dimethyl Fumarate, an active ingredient used in the treatment of multiple sclerosis.

Bird & Bird

Bird & Bird excels in high-stakes litigation in the electronics, telecoms and life sciences segments, and leverages the firm's international network to shine in cross-border matters. Practice head Anne-Charlotte Le Bihan drives complex multi-jurisdictional disputes and strategic portfolio work. Thierry Lautier, a dual-qualified attorney and European patent attorney, strengthens the firm's UPC expertise, whereas Laurent Labatte and Marylis Clerc play pivotal roles in major UPC and French court cases.

Responsables de la pratique:

Anne-Charlotte Le Bihan


Autres avocats clés:

Thierry Lautier; Laurent Labatte; Marylis Clerc


Les références

‘Everything about the team is exceptional: the best lawyers, both technical and legal, were brought together for this very specific case – it would not have been possible to find better assets. The team is highly agile and innovative, both in the legal solutions it proposes and in its methods.’

‘In-depth advice at all times – exceptional listening to find a unique and impactful solution.’

‘A pragmatic approach with excellent knowledge of the industry.’

‘Anne-Charlotte Le Bihan is strategic in court while also possessing in-depth knowledge of the case.’

‘Qualified, efficient and available.’

Principaux clients

Edwards Lifesciences


Honeywell


Nexans


Microsoft


Broadcom


Zodiac


Lesaffre


Minakem


Baxter


Keboda


Nestlé


Dexcom


Akwel


Leko Labs


Nespresso


SATT AST


Greenerwave


PAI


Newmat


Orphalan


I.G.B. S.r.l.


Goodyear


Adalvo


bioMérieux


Valeo


Sinocare


Simtech


Université de Limoges


Reddy Pharma


Institut d’Optique Graduate School


Principaux dossiers


  • Represented Dexcom against Abbott in three parallel cases before the UPC , including the first action ever filed before the Paris Local Division of the UPC.
  • Represented bioMérieux against Qiagen in a disparagement case before the Lyon Commercial Court in relation to a UPC case.

Casalonga

Casalonga stands out for its integrated model uniting patent attorneys and litigators to deliver end-to-end patent services from prosecution and EPO oppositions to national and UPC enforcement and has a wealth of experience in the mechanics, electronics, chemistry, pharmaceuticals, and biotechnology sectors. The team is consists of Arnaud Casalonga, a veteran in cross-border patent disputes, Caroline Casalonga, expert in European patent litigation, Olivier Delprat in mechanics and electronics, Marianne Gabriel in pharmaceuticals and SPCs, Jean-Baptiste Lecoeur in pharmacy and chemistry and Virginie Martin-Charbonneau in chemistry. Ghislain de Trémiolles also works in electronics, software, telecommunications and AI.

Autres avocats clés:

Arnaud Casalonga; Caroline Casalonga; Olivier Delprat; Marianne Gabriel; Jean-Baptiste Lecoeur;  Virginie Martin-Charbonneau; Ghislain de Tremiolles


Les références

‘Casalonga has extensive experience in intellectual property, its defence, and strategy. Their support saves us time and money.’

‘Very high level of competence, very high level of seriousness and creativity’

‘Excellent follow-up on ongoing international cases. The lawyers are dedicated to the cases and have a thorough understanding of them; there’s no need for follow-up.’

‘Arnaud Casalonga, highly experienced and constantly thinking ahead to benefit his client. The team is highly dedicated despite their workload.’

Principaux clients

Safran


L’Oréal


STMicroelectronics


Canon


Sagemcom Broadband SAS


Biogaran


Adeo Group


Vallourec


Renault


TotalEnergies


SKF (Svenska KullagerFabriken)


Michelin


GE Renewable Energy & GE Healthcare


Servier – Les Laboratoires Servier France


Institut Pasteur


Institut Gustave Roussy


Cellectis


Kriptic pharmaceuticals limited


Rio Tinto


Arkema


Auchan


Baker Hughes


Chereau


COFINAIR Group (Jacir)


Diam Bouchage (OENEO Group)


Dianafood


Elis


Etandex (SPPM)


Ethnodyne


Eurecat


Fayat Group


Hisense


Implantica Marketing Limited


Innov’Action


JCR (Ekoï)


Jean Chéreau SAS


MCPP


MSI France


Ortho Partner


PolTreg


Solvay


Teréga


Terumo


Thalgo Group (Perron Rigot)


Université de Genève


Villard Médical


WAFF


Zentiva


Principaux dossiers


  • Defended SAGEMCOM (co-defendant with the operators and other providers) against Intellectual Ventures in a fair, resonable and non-discriminatory (FRAND) patent licensing matter in the telecom industry.
  • Represented BIOGARAN against the MSD/Organon companies in several cases concerning Ezetimibe + Simvastatin (SPC, nullity and infringement).
  • Defended BIOGARAN against BAYER before the Paris Court of First Instance in an action based on patent infringement and nullity.

Gide Loyrette Nouel A.A.R.P.I.

Blending contentious and transactional expertise, Gide Loyrette Nouel A.A.R.P.I. operates comfortably across the pharmaceuticals, medical devices, telecommunications and mechanical innovations segments. The team is co-led by Raphaëlle Dequiré-Portier, a specialist in life sciences and mechanics litigation, Emmanuel Larere, who is well versed in biotech and electronics patents, and Jean-Hyacinthe de Mitry, who is adept in multijurisdictional validity and infringement matters alongside IP transactions. Marie-Ange Pozzo di Borgo represents clients of various industries in cross-jurisdictional patent disputes, both on the merits and in preliminary injunctions.

Responsables de la pratique:

Raphaëlle Dequiré-Portier; Emmanuel Larere; Jean-Hyacinthe de Mitry


Autres avocats clés:

Marie-Ange Pozzi di Borgo; Célia Révy


Les références

‘The team has been responsive and professional in our dealings so far.’

‘Excellent advocacy skills, creative with development of new arguments and options for the client.’

‘Emmanuel Larere and Raphaëlle Dequiré-Portier are both excellent advocates. Marie-Ange Pozzi di Borgo is a rising star senior associate, superbly responsive, and very good at explaining issues in multiple languages.’

‘The team stands out for its rare combination of in-depth legal expertise and a practical understanding of industrial and scientific issues.’

‘We worked primarily with Raphaëlle Dequire-Portier and Célia Révy, whose dedication and complementary skills we greatly appreciate. Raphaëlle Dequire-Portier stands out for her remarkable expertise at the intersection of patent law and pharmaceutical regulations: she combines legal rigour, strategic vision, and a keen understanding of industrial issues.’

‘Célia Révy brings analytical precision and remarkable efficiency to the management of complex cases and technical procedures.’

‘Their support was exemplary, both technically and personally, and the outcome in the case fully met our expectations. Their commitment, attention to detail, and tenacity in defending our company’s interests deserve to be highlighted.’

Principaux clients

ASSIA


Zuru


Meril Life Sciences


Amgen


Boeringher Ingelheim


Minebea (ex U-Shin)


Thomson Licensing


Vantiva


Agri Advanced Technologies


BMS


Celltrion


EDF


Heineken


Meril


Ono Pharmaceutical


Resmed


Retotub


Sanofi


Seratec


Teoxane


Curis


Haulotte


Jacobs Douwe Egberts group


Mnemo Therapeutics


Janssen


ASSIA


Zuru


Meril Life Sciences


Amgen


Boeringher Ingelheim


Minebea (ex U-Shin)


Thomson Licensing


Vantiva


Agri Advanced Technologies


BMS


Celltrion


EDF


Heineken


Meril


Ono Pharmaceutical


Resmed


Retotub


Sanofi


Seratec


Teoxane


Curis


Haulotte


Jacobs Douwe Egberts group


Mnemo Therapeutics


Janssen


Principaux dossiers


  • Representing Meril Life Sciences, a global medical device company operating in more than 100 countries, as the defendant in a new pan-European patent litigation filed by Edwards Lifesciences in France and before the UPC, regarding four of its patents on prosthetic heart valves and delivery systems for the implantation of such heart valves.
  • Representing the pharmaceutical companie BMS in a revocation proceeding brought by Teva, a generic drug manufacturer, to invalidate a patent and the corresponding supplementary protection certificate (SPC), which cover the compound apixaban.

HOYNG ROKH MONÉGIER

HOYNG ROKH MONÉGIER excels as a pan-European IP boutique, renowned for seamless cross-border patent litigation with integrated teams across offices. The team’s portfolio extends to handling high-stakes validity, infringement and disputes over fair, reasonable and non-discriminatory terms for licensing standard-essential patents. The team is led by Sabine Agé, an expert in standard-essential and biotech patents. Denis Monégier du Sorbier represents French and international companies in many sectors, including aeronautics, agriculture and food. Benoît Strowel is an all-round litigator coordinating multi-jurisdictional strategies, while Sophie Micallef works in patent enforcement. Amandine Métier specialises in telecommunications and pharma-related matters. Marta Mendes is another key contact.

Responsables de la pratique:

Sabine Agé


Autres avocats clés:

Benoît Strowel; Sophie Micalleff; Amandine Métier; Marta Mendes; Denis Monégier du Sorbier


Les références

‘Excellent team, proactive and truly dedicated to our business. Excellent cooperation and attentive listening to the internal operations staff to understand and explain patent issues to the judge. We have won all our patent litigation cases.’

 

Principaux clients

AorticLab


Duplo


Egis


Hurom


Illumina


Institut National de la propriété industrielle (INPI)


Magna PT


Michelin


Nintendo


Orange


Prysmian


REGENERON


Sun Patent Trust


Synerlink


AorticLab


Duplo


Egis


Hurom


Illumina


Institut National de la propriété industrielle (INPI)


Magna PT


Michelin


Nintendo


Orange


Prysmian


REGENERON


Sun Patent Trust


Synerlink


Principaux dossiers


Jones Day

Leveraging the firm’s global network, Jones Day demonstrates proficiency in patent and trade secret litigation, while also frequently advising on cross-border enforcement and validity challenges. With established expertise in the life sciences, electronics and mechanics segments, the practice’s portfolio extends to prosecution, oppositions and transactional support. THe team is jointly steered by Thomas Bouvet, a veteran in high-stakes patent disputes across biotech and tech, patent enforcement expert Emmanuel Baud , and Edouard Fortunet, who leads on IP transactions. Colin Devinant focuses on patent validity and infringement litigation, while Eddy Prothiere has experience in matters relating to the electronics, medical devices, mechanics and chemistry industries.

Responsables de la pratique:

Thomas Bouvet


Autres avocats clés:

Emmanuel Baud; Edouard Fortunet; Colin Devinant; Eddy Prothiere


Principaux clients

Infineon Technologies AG


Schwind eye-tech-solutions GmbH


Lufthansa Technik


Daiichi Sankyo


Vibrantz


BioMarin


Coloplast


ProGeLife


Terraillon


Institut Pasteur


Western Australian Agriculture Association


Principaux dossiers


  • Representing chip manufacturer Infineon as defendant in an action for patent infringement based on Standard Essential Patent (SEP) regarding ADSL technology. The action was initiated by Intellectual Ventures against the main French telecom operators, in particular Orange, who purchased its chips from Infineon.
  • Defending Schwind in a patent infringement action brought by competitor Carl Zeiss Meditec on three European patents in connection with Schwind’s flagship surgical laser used for refractive corneal surgery.
  • Representing Lufthansa Technik in its action for infringement against Astronics AES, Panasonic Avionics and Thales Avionics, regarding a European patent on a power supply device for use in aircraft cabins.

Linklaters

Linklaters excels in patent litigation, including UPC actions and complex validity and infringement disputes in the pharmaceuticals, telecommunications and life sciences industries. The practice integrates antitrust expertise for standard-essential patent and FRAND matters while also advising on IP-driven transactions and is co-led by Pauline Debré, a port of call for cross-border enforcement, and Gaëlle Bourout, who was promoted to partner in May 2025 and specialises in life sciences patents. Laetitia Nicolazzi advises clients on the drafting and negotiation of contracts related to artwork commissioning, assignment of rights and licensing agreements.

Responsables de la pratique:

Pauline Debré; Gaëlle Bourout


Autres avocats clés:

Laetitia Nicolazzi


Les références

‘The IP team handling our cases is simply excellent: they handle complex cases with unparalleled acuity and legal expertise. In addition, they are completely available to ensure seamless management of matters in case of urgent need.’

‘ High degree of excellence and exacting standards, good client communication, sound advice during negotiations, strategic approach.’

‘Particularly strong in SEP litigation in Europe. I especially appreciate the diversity of the team working on our matter. ’

Principaux clients

Seoul Semiconductor Ltd


Intel Corporation


John Cockerill Hydrogen


Sanofi


Regeneron


Principaux dossiers


  • Advising and representing Seoul Semiconductor in their global enforcement campaigns against major competitors and their distributors in key jurisdictions.
  • Representing Intel’s affiliate Intel Germany in an infringement action relating to a patent essential to the ADSL standards (standard essential patents, “SEPs”), launched by Intellectual Ventures II (“IV”) against internet provider Orange, which subsequently judicially requested various parties to join the proceedings, including Intel (chipset provider to Orange’s DSLAM provider).

Schertenleib

Schertenleib stands out as exclusively dedicated to patent litigation with noteworthy strength in the life sciences and pharmaceuticals industries. The practice excels in high-stakes disputes, regulatory counsel and multi-jurisdictional matters and is headed by founder Denis Schertenleib, a physicist with a PhD in molecular neurobiology focusing on patent litigation, arbitration and pharma regulatory matters. Ombeline Degèze-Péchade is renowned for innovative patent and regulatory strategies, and Marc Lauzeral is a name to note for cross-border patent and SPC disputes.

Responsables de la pratique:

Denis Schertenleib


Autres avocats clés:

Ombeline Degèze-Péchade; Marc Lauzeral


Les références

‘The Schertenleib team comprises highly skilled lawyers known for their sharp analytical minds and extensive patent litigiation experience, in particular in the pharmaceutical and life sciences sectors. Their profound understanding of the technical and scientific background enables them to deliver comprehensive legal analysis and advice that meticulously considers all relevant aspects. They are diligent, deeply committed, exceptionally knowledgeable, and consistently responsive.’

‘I truly appreciate collaborating with Ombeline Degrèze-Péchade and her team. She is remarkably responsive and accessible, offering outstanding legal advice thanks to her deep legal and scientific expertise and the many years of experience. Above all, working with her is always a genuine pleasure. Ombeline and the Schertenleib team are undoubtedly the top choice for all matters related to patent litigation, in particular in a pharmaceuticals context.’

‘A multidisciplinary team providing precise and efficient service tailored to each situation. No topics are off-limits in discussions; they take all of their clients’ concerns into account.’

‘The firm is highly specialist and has detailed technical experience. It is focussed on delivering the best possible outcomes for clients.’

‘Denis Schertenleib is a statesman of patent litigation. He drafts fully articulated and detailed arguments that leave no stone unturned.’

‘Marc Lauzeral is energetic and deftly able to navigate the interpersonal with his excellent communication skills.’

 

Principaux clients

Recor Medical Inc. & Otsuka Medical Device


Viatris


Neuraxpharm


Akwell Vigo Spain


Sandoz


Zentiva


C-KORE


Filorga


Fill-Med


TCL


Bio-Rad


Principaux dossiers


  • Represented Sandoz successfully in invalidity proceedings against Bayer’s patent relating to Rivaroxaban (marketed as Xarelto), one of Bayer’s blockbuster drugs and a strategic product for the client’s European portfolio.
  • Represented Viatris successfully in litigation initiated by Biogen before the Paris Court of First Instance, concerning dimethyl fumarate (DMF)—one of Biogen’s blockbuster drugs used in the treatment of multiple sclerosis.
  • Represented ReCor Medical Inc. and Otsuka Medical Devices Europe GmbH successfully in invalidity proceedings against Medtronic’s patent relating to an ultrasound renal neuromodulation device.

Simmons & Simmons

Simmons & Simmons' pan-European patent litigation practice integrates dual-qualified experts for seamless prosecution, oppositions and enforcement advice across the telecoms, electronics and life sciences industries. The team excels in cross-border disputes before national courts and the UPC, offering strategic advice on standard-essential patents and fair, reasonable and non-discriminatory licensing terms. The team is co-led by Abdelaziz Khatab, a veteran in high-stakes validity and infringement actions, Sarah Bailey, and digital innovations specialist Georgie Courtois, who joined from De Gaulle Fleurance & Associés in June 2025.Mickaël Da Costa departed in May 2025.

Responsables de la pratique:

Abdelaziz Khatab; Sarah Bailey; Georgie Courtois


Les références

‘Simmons & Simmons stands out for combining deep technical expertise with a strategic business perspective. Its patent team includes professionals with multidisciplinary backgrounds, allowing precise and commercially focused solutions across diverse technologies.’

‘The professionals at Simmons & Simmons stand out for their technical depth, strategic thinking, and genuine commitment to client success. They combine precision in patent prosecution with a practical understanding of business and innovation needs.’

‘Abdelaziz Khatab deserves special recognition for his exceptional dedication and expertise, particularly in handling the restoration of an important patent for one of our clients. His proactive approach, attention to procedural detail, and clear communication were instrumental in achieving a successful outcome. Overall, the team’s professionalism, reliability, and collaborative spirit make them a trusted and valued partner in all IP matters.’

‘We were very satisfied with the service provided.’

‘Our lawyer was Abdelaziz Khatab. He was very available and attentive to the issues related to the research area covered by the patent. The discussions were always interesting and very constructive in finding solutions.’

‘Attentive, available, highly skilled in her areas of expertise and proactive in finding the right solutions.’

‘The team is responsive and well-managed by Abdelaziz Khatab, a recognised expert in his field.’

‘Abdelaziz Khatab is particularly distinguished by his dual expertise as a European patent attorney and as a lawyer. He can therefore handle all matters relating to patent law (contentious and non-contentious). His expertise is widely recognised in the field of patents.

Principaux clients

Thales


Cooper Consumer Health


Network System Technologies


Tarkett


Stryker


Sibionics


Samsung Bioepis


Xiaomi


Honeywell


Servier


Nanjing Kangni Mechanical & Electronical co. Ltd


Daewoo Shipbuilding & Marine Engineering


Metavonics


Trasis


Flexikeg


ID SIDE


Genvia


Généthon


Ecoat


Alkermes


Merck KGaA


Dana-Farber Cancer Institute


Principaux dossiers


  • Representing Samsung Bioepis in a revocation action, part of a pan-European dispute, against Alexion to clear the way for Samsung Bioepis’ launch of its skinny-label biosimilar eculizumab product, a counterpart to Alexion’s blockbuster drug Soliris.
  • Representing Thales DIS, a French subsidiary of the Thales Group, which operates in the defence, aerospace, cyber, and digital sectors, in a patent dispute against Okta, a competitor in the field of internet security and identification technologies, concerning secure communications over the internet (Multi Factor Authentication).
  • Representing Trasis, a player in the radiopharmaceutical industry, in a patent dispute against Out and Out Chemistry concerning a method for performing a series of synthesis processes to prepare radiopharmaceuticals, as well as a device and cassette designed for this method.

Abello IP Firm

Abello IP Firm

A&O Shearman

A&O Shearman specialises in high-stakes pharmaceutical and tech disputes with the team’s area of expertise encompassing preliminary junction proceedings and litigation with mulit-jurisdictional elements. Global IP litigation head Laëtitia Bénard leads the practice and is adept at life sciences enforcement and defending blockbusters against generics. Charles Tuffreau is recommended for UPC litigation, validity challenges and infringement seizures, leveraging engineering expertise for complex tech cases. Elise Romelly is a key contact for pharma litigation and transactional work.  David Por left the team in March 2025.

Responsables de la pratique:

Laëtitia Bénard


Autres avocats clés:

Charles Tuffreau; Elise Romelly


Les références

‘Charles Tuffreau and Elise Romelly are excellent lawyers. They listen carefully to their clients and provide clear recommendations.’

‘Very structured, sound and timely legal advice for a complex patent litigation. The team has worked quickly and also leading other outside counsel input. Even with tight timelines, all workproduct was on point. ’

‘Laëtitia Bénard led the team and additional outside counsel in a very structured manner. The high level of knowledge and on point presentation in court were highly appreciated. ’

Principaux dossiers


Dentons

Dentons fields various litigation experts and  integrates global resources for cross-border enforcement in the life sciences, IT and pharmaceuticals segments. The practice demonstrates strength in validity disputes, SPCs and trade secret audits, offering tailored strategies for innovation protection and is led by Loïc Lemercier, a specialist in high-stakes infringement and ownership claims, who is well supported by Tom Blanchet

Responsables de la pratique:

Loïc Lemercier


Autres avocats clés:

Tom Blanchet


Les références

‘Reliability, competence, trust. Outstanding.’

Principaux clients

CNRS


ARJO


Fresenius Kabi Biopharma


MabSilico


Apple


EOS Imaging


Magnier LLC


My Robotics


Softbox


Septodont


Chanel


Principaux dossiers


  • Representing Apple in a cross-border patent litigation dispute brought by Mr Ferid Allani before the Paris Court.
  • Representing ARJO in a patent litigation against Nausicaa Medical.
  • Representing CNRS in a dispute with a former employee, who served as CNRS director of scientific research, regarding additional remunerations that should allegedly have been paid for the exploitation of several patents (35 patents are concerned) relating to lithium batteries.

DTMV & Associés

DTMV & Associés‘s portfolio encompasses patent litigation, validity challenges and trade secret disputes across pharmaceuticals, electronics and telecoms. The practice excels in multijurisdictional enforcement, leveraging deep technical expertise for defense strategies. Thierry Mollet-Viéville covers the full spectrum of IP law with a focus on international patent litigation and a wealth of experience in the pharmaceuticals segment, while  Pascal Lefort a name to not for clients seeking support with automotive innovations. Further important team members include the expert for technology patents  Eleonore GasparThomas Cuche, who handles SEP disputes, and Grimaud Valat, whose practice covers the full range of digital IP transactions.

Autres avocats clés:

Thierry Mollet-Viéville; Pascal Lefort; Eléonore Gaspar; Thomas Cuche; Grimaud Valat


Les références

‘The DTMV team is very dedicated and attentive to its clients.’

‘Thomas Cuche is the partner with whom we collaborate regularly. I particularly appreciate the simplicity and efficiency of our exchanges. Highly attentive to his clients’ needs and interests, Thomas knows how to develop creative solutions to resolve pre-litigation situations and restore calm when tensions rise.’

‘The team is highly responsive. I have complete faith that they will keep to the agreed timeframe for a project and communicate their progress clearly. They consider all issues in detail.

Principaux dossiers


Herbert Smith Freehills Kramer LLP

Herbert Smith Freehills Kramer LLP's multidisciplinary offering includes patent litigation, prosecution, post-grant proceedings and licensing, particularly in the technology, internet and life sciences sectors. The practice adeptly handles complex domestic and UPC disputes alongside strategic advice on emerging innovations. The team is led by Alexandra Neri, who is renowned for  patent enforcement in the digital and consumer tech spaces. Emmanuel Ronco is a specialist in patent-dependent transactions and AI compliance, Vincent Denoyelle is well wersed in data-driven patent strategies, and Sébastien Proust is adept in software and tech patent conflicts. Frédéric Chevallier departed in June 2025.

Responsables de la pratique:

Alexandra Neri


Autres avocats clés:

Emmanuel Ronco; Vincent Denoyelle; Sébastien Proust


Principaux dossiers


Hogan Lovells (Paris) LLP

Hogan Lovells (Paris) LLP boasts a formidable pan-European patent litigation practice, excelling in cross-border validity, infringement and trade secret disputes across the life sciences, telecommunications and electronics industries. The team combines experience in multijurisdictional matters with technical expertise, delivering pragmatic enforcement and defense solutions and is led by Stanislas Roux-Vaillard, who is recommended for high-stakes patent disputes and UPC proceedings. Adrien Bonnet offers niche expertise in aerospace patent defence.

Responsables de la pratique:

Stanislas Roux-Vaillard


Autres avocats clés:

Adrien Bonnet


Principaux clients

Eli Lilly


Hollister


Astronics


Guangdong OPPO Mobile Telecommunications Corp; Ltd


Orange SA


Mul-T-Lock


F. Hoffmann La Roche AG


Eli Lilly


Hollister


Astronics


Guangdong OPPO Mobile Telecommunications Corp; Ltd


Orange SA


Mul-T-Lock


F. Hoffmann La Roche AG


Principaux dossiers


  • Representing F. Hoffmann La Roche in defending their formulation patents on their blockbuster product Herceptin in a multijurisdictional validity challenge initiated by Indian generics manufacturer Accord.
  • Representing Orange before the Court of Appeal of Paris to seek confirmation of a judgment regarding the freedom of Orange to operate without infringing patents of US company ASSIA.
  • Representing Mul T Lock before the UPC in a case where the Court rendered the first post-Electrolux CJEU decision on jurisdiction and the UPC found it has long-arm jurisdiction to find infringement in non-UPC countries such as the UK, Spain and Switzerland.

Jeantet

Jeantet‘s focus areas encompass cross-border patent enforcement and validity disputes with particular proficiency in the biotech, life sciences and mechanics sectors. The team provides advice on innovation protection, including litigation to licensing and audits. The team is co-led by Benjamin May, an expert in multi-jurisdictional infringement actions who joined from Aramis in January 2025 and Frédéric Sardain, a specialist in technology transactions and data compliance. Tristan Cassagne is another name to note.

Responsables de la pratique:

Benjamin May; Frédéric Sardain


Autres avocats clés:

Tristan Cassagne


Les références

‘Benjamin May is an experienced patent litigator, business minded and very responsive. While his focus in patent disputes is life sciences, his comprehensive experience in IT-/Data law enables him well to take on work in other technical fields / industries. ’

‘The Jeantet team is serious, has excellent interpersonal skills, good communication with intermediaries on its cases and a clear strategy.’

‘Benjamin May is very involved in his cases, has in-depth knowledge in his field, and seeks to get the best out of the service providers he works with.’

Principaux clients

Fresenius Medical Care


Belmoca and AluSense


Preformed Line Products


Zentiva France


DSM-Firmenich


Out & Out Chemistry


Ligier


Principaux dossiers


  • Assisting Fresenius Medical Care in a pan-European litigation against Nipro regarding the infringement and validity of a European patent related to a medical device in the field of dialyzers. The case was heard by the Paris Court in May 2024 and the first instance decision was issued in September 2024.| |An appeal was lodged against this first instance decision. Benjamin May’s IP team now assists Fresenius Medical Care before the Paris Court of appeal. The case is currently pending.
  • Assisted Preformed Line Products successfully in several investigation orders in various locations, as well as enforcing EP patents against competitors on the market of telecommunications connectors.
  • Assisted Zentiva in a major patent case brought by a major actor in the medical sector based on a patent infringement and unfair competition.

Pinsent Masons LLP

Pinsent Masons LLP 's sector-driven patent practice focuses on the life sciences, electronics and telecoms segments and is adept at coordinating pan-European infringement and validity disputes before national courts and the UPC. The team integrates contentious enforcement with strategic patent prosecution and oppositions, offering pragmatic solutions for innovation protection. The group is led by Virginia de Freitas, an expert in cross-border patent litigation who was promoted to partner in May 2025. Former practice head Jules Fabre departed  in April 2025.

Responsables de la pratique:

Virginia de Freitas


Principaux clients

Advanced Cell Diagnostics


Global Wheel


Georg Martin


Precitec


Asentys


Aldes


4D Pharma


Landys + Gyr


Principaux dossiers


  • Representing Advanced Cell Diagnostics, a US company acting in the field of spatial genomics and spatial transcriptomics, in an infringement action filed before the UPC against one of its main competitors in relation to kits for multiplexed, quantitative, high-resolution bioimaging in academic research, drug development, and clinical pathology and diagnostics.

Taliens

Taliens, a Franco-German IP boutique, excels in cross-border patent enforcement and validity disputes, while also demonstrating proficiency in infringement actions, SPC proceedings and trade secret protection. The group is co-led by Grégoire Triet, experienced in life sciences patent disputes, and Jean-Frédéric Gaultier, a specialist in tech patent litigation. Both are well supported by Tougane Loumeau and Sophia Gintersos.

Responsables de la pratique:

Jean-Frédéric Gaultier; Grégoire Triet


Autres avocats clés:

Tougane Loumeau; Sophia Gintersos; Clara Steinitz


Les références

‘A niche firm with top-quality professionals: excellent lawyers, very good drafters and litigators, capable of thinking outside the box.’

Principaux clients

ArcelorMittal


AstraZeneca / AstraZeneca ABC


lifford Chance


EisaiEnvases / Envases & Scanavo


Johnson & Johnson/Janssen


Lens Correction Technology (LCT)


NemeraRockwool


SBM Offshore / Single Buoys Mooring (SBM Offshore)


SPPM


ZTE


Principaux dossiers


Bignon Lebray

Bignon Lebray excels in infringement, validity and ownership disputes across the life sciences, biotech and pharmaceuticals sectors. The practice provides innovation strategies ranging from research and development agreements to licensing and regulatory compliance and is headed by Nicolas Moreau, who shines in transactional matters. Barbara Bertholet is well versed in patent enforcement.

Responsables de la pratique:

Nicolas Moreau


Autres avocats clés:

Barbara Bertholet


Les références

‘Expertise and availability.

‘Barbara Bertholet: pleasant and competent.’

‘Serious and very professional.’

Principaux clients

Sandoz


Principaux dossiers


  • Represented a Global Pharmaceutical Group in a dispute before the French courts involving alleged infringement of a supplementary protection certificate (SPC) and unfair competition.
  • Advised a French biotech company on the negotiation of a cross-border patent licensing agreement with a Swiss CDMO.
  • Acting as co-counsel in a patent infringement case pending before the Düsseldorf division of the Unified Patent Court (UPC). The matter concerns mechanical technology and involves coordination with German counsel on cross-jurisdictional strategy, procedural tactics under the UPC framework, and a comparative legal approach to infringement and validity challenges.

De Gaulle Fleurance & Associés

De Gaulle Fleurance & Associés sets itself apart through its integrated approach, enabling seamless cross-practice collaboration on patent litigation, validity disputes and R&D transactions across. The practice is jointly steered by Louis de Gaulle, who is recommended for the full range of commercial patent enforcement, Julien Horn, an expert in IT-patent litigation, Francine Le Péchon-Joubert, who frequently supports clients in trade secret defenses, and Cécile Théard-Jallu, a specialist in healthcare regulations and data-driven IP contracts.

Responsables de la pratique:

Louis de Gaulle; Julien Horn; Francine Le Péchon-Joubert; Cécile Théard-Jallu


Autres avocats clés:

Charlotte Hébert-Salomon; Adèle Binnié


Les références

‘I have been very impressed by this firm. They have great depth of knowledge and experience in IP.’

‘Julien Horn is excellent – he gives great confidence but is reserved and calm. He has considerable experience and seems to be well respected by the judges. I would have no hesitation in recommending him.’

 

Principaux clients

Alstom Transport


Energy Observer Developments


EUROPEENNE DE BIOMASSE


Filorga


FinX


Gallagher


Hoya Surgical GmbH


HYPERION


ILE-DE-FRANCE MOBILITES


Nectra


Pierre La vista / Gaia


PIERRE FABRE


TotalEnergies


Tyron Runflat Ltd


Principaux dossiers


Gowling WLG

Gowling WLG frequently acts in cross-border disputes before French courts and the UPC, offering integrated enforcement, FRAND licensing, and innovation protection advice with particular strength in the life sciences, telecommunications and technology segment. The practice is co-headed by Céline Bey, who is well versed in infringement actions, and Marianne Schaffner, an expert in multi-jurisdictional validity challenges. Alexis Augustin focuses on pharmaceutical disputes.

Responsables de la pratique:

Céline Bey; Marianne Schaffner


Autres avocats clés:

Alexis Augustin; Huw Evans


Les références

‘The team has a very high level of expertise. It is always a pleasure to work with them.’

‘Alexis Augustin is very reliable and always available. Everything runs in a very structured and harmonious manner.’

‘They have excellent abilities across the board and are adaptable to different technologies.’

‘They provide a very clear explanation of the process and the risks and costs involved.’

‘The Gowling team excels in a number of fronts – its people are top notch in expertise and communication skills; they function as a true team focused on ensuring the best quality advice and outcome for the client. They are a diverse team that collaborates seamlessly.’

‘Standout partners are certainly Marianne Schaffner and Huw Evans. Brilliant in different ways. Marianne is an expert in litigation strategy and execution – she can go deep into the merits of a case and the legalities associated with the case but also is able to stay high level when necessary and communicate overarching issues to business clients. Huw brings the client care aspect to the team and is able to bring in additional Gowling partners as needed.’

‘Marianne Schaffner is a great lawyer.’

 

Principaux clients

Molecular Instruments


Principaux dossiers


  • Representing Molecular Instruments, Inc. in its defence to a patent infringement action before the UPC at The Hague Local Division further to a UK counterpart case in which the GB designations of the asserted patents were revoked.
  • Representing Acome in a patent infringement action in France.

Lavoix

Lavoix houses both patent attorneys and dedicated litigators to provide clients with a full-service full service offering covering patent prosecution, opposition and litigation support.  The practice handles infringement, validity and ownership disputes before French courts and the UPC, and advises on licensing and technology transfer contracts. The practice is led by Camille Pecnard, who is experienced in multijurisdictional patent enforcement, and Pierre Emmanuel Meynard, who excels at the intersection of pharmaceutical regulatory and patent law. Martin Simonnet is a name to note for technology disputes.

Responsables de la pratique:

Camille Pecnard


Autres avocats clés:

Pierre Emmanuel Meynard; Martin Simonnet; Bertrand Domenego


Les références

‘Professionalism with empathy and competence.’

‘Good advocacy skills and experience in French litigation, backed by an eminent patent prosecution practice. ’

‘Camille Pecnard is an impressive and experienced litigator, very easy to communicate with and with a sensible approach.’

Principaux clients

NEOPERL


MATEST


NANTES UNIVERSITE


INSERM / INSERM TRANSFERT / NANTES UNIVERSITÉ


VOLKSWAGEN AG


WOLFGANG SCHMAUSER


ARCELORMITTAL


UNITEC SpA


LAVAZZA PROFESSIONAL FRANCE


SBM


Principaux dossiers


  • Representing ArcelorMittal in a patent infringement case before the UPC, as well as before the US and Chinese courts, against several main competitors and car manufacturers (around 17 different entities) regarding the manufacture of several cars implementing its patents.
  • Represented clients in a a patent ownership claim action.
  • Represented Volkswagen AG and one of its retailers in France in a case brought by a manufacturer of engine parts regarding a litigious mechatronic assembly.

Osborne Clarke

Osborne Clarke is renowned for its strength in patent prosecution, litigation and portfolio management. The team is co-led by Claire Bouchenard, who has authority in advertising and marketing IP disputes and Xavier Pican, a specialist in blockchain and data licensing. Julia Darcel is recommended for enforcement matters, while Christophe Arfan demonstrates proficiency in metaverse interllectual property protection.

Responsables de la pratique:

Claire Bouchenard; Xavier Pican


Autres avocats clés:

Julia Darcel; Grégoire Dumas; Laurène Zaggia; Marie-Laure Pidoux; Christophe Arfan


Les références

‘All lawyers are highly trained professionals who closely coordinate strategies with their clients. A key strength is their ability to provide concrete answers to client questions; OC anticipates the client’s situation, reflects on the facts, and offers excellent recommendations.’

‘I appreciate a high level of availability and a real added value in the review of cases.’

‘A very available, loyal, proactive team that respects deadlines.’

 

Principaux clients

Gesamtverband Autoteile-Handel E.V (GVA)


Principaux dossiers


  • Advised an global supply chain services group in pre-litigation matters.
  • Assisted a fully integrated, global immunotherapy powerhouse in securing a non-exclusive license for a patent family concerning a platform technology.
  • Assisting a client active in sustainable construction in the framework of negotiation of four patent licensing agreements in exchange for the withdrawal of oppositions with an American competitor.

ADVANT Altana

ADVANT Altana's focus areas include patent litigation, licensing and portfolio strategy, with the team offerng a wealth of experience in the  life sciences, technology and consumer goods sectors. The team provides integrated advisory on infringement, validity and R&D contracts, with strong cross-border coordination via the ADVANT alliance and is jointly steered by Pierre Lubet, a port of call for technology disputes, Laura Morelli , who excels  in healthcare enforcement, and Jean-Guy de Ruffray.

Responsables de la pratique:

Pierre Lubet; Laura Morelli; Jean-Guy de Ruffray


Autres avocats clés:

Armand Aviges; Camille Raclet; Claire Borgel; Clémence Aladjidi


Les références

‘Professional and pragmatic.’

‘The team is made up of people who are very attentive to their clients and whose skills complement each other perfectly.’

‘Jean-Guy de Ruffray has the talent to listen to his clients and to prevent them from making mistakes. He is particularly adept at navigating complex ridge paths.’

 

Principaux clients

ISENTRONIQ


AXIANS (VINCI ENERGIE)


AMPHENOL CORPORATION


ELECTROLUX


WIENERBERGER


VDLV


JACQUET PANIFICATION


INDIGO


DIAM GROUP


FAURECIA (FORVIA)


Principaux dossiers


  • Representing FAURECIA in ongoing patent, know-how and contract-related litigation.
  • Representing AXIANS (Vinci Energie) in a ongoing litigation for patent infringement against a competitor.
  • Representing JACQUET PANIFICATION in an ongoing patent and design infringement action against one of its competitors

BCTG Avocats

BCTG Avocats offers litigation and advisory services, focusing on infringement, revocation, ownership disputes, as well as strategic IP management. The team provides end-to-end support, from patent protection and licensing to anti-counterfeiting and cross-border enforcement and is headed by Gaëlle Bloret-Pucci, who brings experience in  multi-jurisdictional disputes for luxury and retail clients.

Responsables de la pratique:

Gaëlle Bloret-Pucci


Les références

‘Strengths and assets: responsiveness, structured argument, relevance of analysis, methodology, strategy, advocacy.’

‘Gaëlle Bloret-Pucci stands out for the quality of her contributions and analyses, both oral and written.’

‘The team is extremely responsive and efficient. Their advice is very clear and provides us with real support.’

‘Gaëlle Bloret-Pucci is an available contact person, very competent and very clear in her advice.’

Principaux clients

Louis Vuitton Malletier


Christian Dior Couture


Givenchy


Kenzo


Nike


Converse


Jordan


Eg Labo – Stada Arzneimittel AG


Principaux dossiers


Clifford Chance

Clifford Chance operates comfortably across cross-border litigation, infringement, revocation, and transactional matters, withparticular strength in the technology, life sciences, and energy sectors. The team coordinates pan-European disputes, including UPC cases, and advises on licensing, trade secrets, and regulatory issues. Practice head David Por joined from A&O Shearman in March 2025 and focuses on high-profile patent enforcement and SEP/FRAND disputes. A dual-qualified lawyer and engineer specialising in patent litigation, Cyril Riffaud joined alongside Por.

Responsables de la pratique:

David Por


Autres avocats clés:

Cyril Riffaud


Les références

‘They are very good, one of the best on patent litigation in France, especially in an international context. Further, they have very strong teams also in other jurisdictions.’

‘David Por is an excellent patent litigator. He is fluent in French and English and makes innovative arguments, even when case law might be against him.’

Principaux clients

Air Liquide


MGI


Nokia


Samsung Electronics


Assa Abloy


Eastern Pacific Shipping


Archos


TotalEnergies


3M


Nobel Biocare


Principaux dossiers


CMS Francis Lefebvre

CMS Francis Lefebvre handles a busy workload, including infringement and revocation actions, as well as advice on R&D contracts, licensing, and portfolio audits, combining patent expertise with capabilities in regulatory and tax aspects. Important team members include Jean-Baptiste Thiénot, who excels at the intersection of contentious patent issues and life sciences regulation and offers niche expertise in and employee inventiontopics.

Autres avocats clés:

Jean-Baptiste Thiénot; Anne-Laure Villedieu; Florentin Sanson; Sabine Rigaud


Les références

‘A team made up of high-quality professionals, attentive to clients and creative.’

‘Jean-Baptiste Thiénot is a very good adviser,  who is attentive to his clients and offers varied solutions to achieve the desired objective.’

‘Collaborative teamwork.’

 

Principaux clients

Leifheit


E-Diagmed


Trilogiq


Amosan Distribution – Amosan Petrochemicals – Green Source


Principaux dossiers


  • Advising an industrial group (Amosan – Green Source) on entering a tightly controlled automotive parts market, facing pressure from a competitor, including securing a win with the Court rejecting a preliminary injunction.
  • Defended Trilogiq in a patent infringement case against its main competitor, Geolean and secured a win upheld on appeal, along with damages, a permanent injunction, and product destruction.
  • Represented Leifheit in a patent infringement action which led to a settlement through an innovative procedural path.

DLA Piper

DLA Piper provides focused patent counsel in France, supporting global clients with infringement, validity and licensing disputes in life sciences, technology and consumer sectors. The practice offers pragmatic strategies for portfolio management and cross-border enforcement. The team is led by Frank Valentin, experienced in high-value patent litigation and supported by associate Cédric Meiller, who plays a key role in complex validity challenges and trade secret audits.

Responsables de la pratique:

Frank Valentin


Autres avocats clés:

Cédric Meiller


Principaux clients

Laboratoires Vivacy


Principaux dossiers


Goodwin

Goodwin is renowned for its end-to-end patent counsel in the life sciences and technology segments,with the team's portfolio ranging from licensing and collaborations to litigation and regulatory advice. The practice frequently supports venture-backed innovators through financings, M&A and royalty monetisations, leveraging deep sector fluency for strategic asset protection. Practice head Marie Fillon demonstrates strength in cross-border biotech deals.

Responsables de la pratique:

Marie Fillon


Les références

‘Marie Fillon is recommended for IP transactional matters.’

‘The team is exceptional, distinguished by its expertise and strategic understanding of business challenges, combined with its availability and ability to handle cases within very short timeframes in a collaborative spirit.’

‘Marie Fillon stands out for her sharp technical skills, her rigor, and her ability to provide pragmatic and effective solutions with a strategic mindset. Always responsive and with a collaborative attitude, she makes interactions easy, enriching, and extremely satisfying.’

 

 

Principaux clients

Andera Partners


Bpifrance


Biomunex Pharmaceuticals


Exor Ventures


GENFIT


Germitec


LocalGlobe


Micropep Technologies


Novo Holdings


One Peak


Plural


Sofinnova Partners


Stilla Technologies


Speedinvest


Syntetica


Principaux dossiers


  • Advised listed company GENFIT on a non-dilutive capped royalty financing agreement with HealthCare Royalty (HCRx) for up to €185m in exchange for a portion of the royalties on sales a prescription medicine used to treat primary biliary cholangitis.
  • Advised Biomunex on its exclusive global licensing agreement with Ipsen for the BMX-502 program.
  • Advised Stilla Technologies on the signing of a put option agreement for the acquisition, in particular the related IP aspects, of Stilla Technologies by Bio-Rad.

Squire Patton Boggs

Squire Patton Boggs  handles infringement litigation, cancellation actions, ownership transfers, and related contracts for international clients in the electronics, transportation, pharmaceuticals, energy, media, telecommunications, and software sectors. The team also operates comfortably across licensing, unfair competition, and IT-related disputes, with a focus on cross-border matters. Practice head Catherine Muyl offers a wealth of experience in patent litigation and enforcement matters. Marion Cavalier supports on both contentious and advisory work.

Responsables de la pratique:

Catherine Muyl


Autres avocats clés:

Marion Cavalier; Florence Cotillon


Les références

‘A dynamic team that studies cases in minute detail and doesn’t hesitate to investigate to obtain all the information.’

‘Catherine Muyl is recommended for her extensive experience, Marion Cavalier for her global vision and proactive approach.’

‘Highly professional and efficient. Excellent anticipation of our needs. This was particularly important given the inherent difficulty lawyers face in having to warn about all sorts of risks.’

Principaux clients

Mobiwire


Principaux dossiers


  • Representing a global Asian company in a patent validity and infringement dispute in the field of maritime transport.
  • Representing a leading global manufacturer of packing company in a patent infringement dispute relating to food packaging.
  • Advising Mobiwire’s IP counsel on the negotiation of patent license agreements over essential and telecom patents.

Taylor Wessing

Taylor Wessing's areas of expertise include cross-border litigation, technology transfers, and innovation strategies, with strength in the pharmaceuticals, life sciences, technology, electronics, energy, and transportation segments. Frequently coordinating pan-European disputes and advising on regulatory issues, the team is led by Jules Fabre, who joined from Pinsent Masons LLP in May 2025 and focuses on high-stakes patent and SPC litigation for generics and biosimilars. Marina Jonon also joined from Pinsent Masons LLP in May 2025 and handles life sciences disputes. Clémence de Marassé-Enouf joined from A&O Shearman in June 2025, bolstering the firm's offering regarding enforcement in the pharmaceuticals and technology sectors.

Responsables de la pratique:

Jules Fabre


Autres avocats clés:

Marina Jonon; Clémence de Marassé-Enouf


Les références

‘Highly adept patent litigation team who routinely and successfully handles highly complex patent litigation projects. They are highly knowledgable, strategic thinkers and a pleasure to work with.’

‘Jules Fabre is a great leader and an exceptional lawyer. He has the ability to rapidly grasp highly complex aspects of patent disputes and effectively manage his team. He is also a valued and productive member of larger teams working on multi-jurisdictional projects. Would highly recommend.’

Principaux clients

Formycon


Global Wheel


Accord Healthcare


Zentiva


Georg Martin


Precitec


Asentys


Griesson de Beukelaer


Aldes


Klinge


Fresenius Kabi


Rodenstock


Roof International


Advanced Cell Diagnostics


Stragen


Principaux dossiers


  • Representing Accord Healthcare in a pan-European mandate to support market access and coordinating litigation for a biosimilar of Roche’s blockbuster monoclonal antibody.
  • Representing Accord in patent litigation against Sanofi in connection with Accord’s generic version of Sanofi’s blockbuster prostate cancer treatment, including proceedings before the UPC Munich Local Division and parallel actions in France, where the team successfully defended a fast-track preliminary injunction application before the Paris Court of First Instance.
  • Representing and successfully defending Zentiva in the context of an application for a fast-track preliminary injunction from Bayer against the contemplated launch of Zentiva’s generic rivaroxaban (Xarelto) product in France.